{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:02:04Z","timestamp":1790262124966,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microglial colony-stimulating factor-1 receptor (CSF1R) is a therapeutic and imaging target, yet the regional, disease-specific distribution of CSF1R-positive microglia in the human brain remains incompletely defined, limiting interpretation of emerging CSF1R-PET signals. We sought to build a cross-disease, multi-region, quantitative map of CSF1R-positive microglia in neurodegenerative conditions and progressive multiple sclerosis (MS) lesions, with an exploratory comparison to presynaptic marker burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CSF1R mRNA\u2011positive microglia were quantified by RNAscope across six cortical regions (MFG, IFG, ITG, AG, CA1, EC) in early\u2011onset Alzheimer's disease (EOAD), late\u2011onset AD (LOAD), progressive supranuclear palsy (PSP), and frontotemporal lobar degeneration with TDP-43 inclusions due to progranulin mutation (FTLD\u2011GRN), and in primary and secondary progressive MS (PPMS, SPMS) within cortical gray\u2011matter plaques, plaque-adjacent gray matter and white matter. Positivity was defined a priori as\u2009\u2265\u20093 puncta with housekeeping\u2011probe pass and negative\u2011control verification, counting blinded, and densities were cortical\u2011thickness corrected. Iba-1 immunolabeling verified microglial identity. Western blot provided protein\u2011level verification. We explored ROI\u2011level associations of CSF1R with SV2A and synaptophysin previously measured in the same regions\/cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In neurodegeneration, increases were smaller and region\u2011specific (e.g., EOAD\u2014ITG\/CA1; LOAD\u2014AG; PSP\u2014AG; FTLD\u2011GRN\u2014IFG\/ITG\/AG\/EC), with minimal white\u2011matter change. In progressive MS, gray-matter CSF1R-positive microglia densities did not differ from controls, whereas SPMS white matter was increased. Exploratory analysis showed that CSF1R and SV2A were positively associated across ROIs in neurodegenerative diseases (e.g., PSP approximately \u03c1\u2009=\u20090.66), and weakest in LOAD; synaptophysin showed similar patterns, suggesting that regions with higher CSF1R-positive microglia density can coincide with relative preservation of presynaptic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A cross\u2011disease, region\u2011resolved map reveals region\u2011specific changes in CSF1R\u2009+\u2009cell density in neurodegeneration, but only white matter in MS. These findings provide the histological context needed to interpret future CSF1R\u2011PET. Prospective studies pairing CSF1R\u2011PET with SV2A\u2011PET and multiplex tissue profiling are warranted to define microglial states and synaptic outcomes in vivo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-026-03945-6","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:05:19Z","timestamp":1783123519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses"],"prefix":"10.1186","volume":"23","author":[{"given":"Mahsa S.","family":"Bavarsad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina M.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Satpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-0618","authenticated-orcid":false,"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"1","key":"3945_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"key":"3945_CR2","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10:1008.","journal-title":"Front Pharmacol"},{"issue":"36","key":"3945_CR3","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929\u201347.","journal-title":"J Neurosci"},{"issue":"6","key":"3945_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","volume":"39","author":"V Chitu","year":"2016","unstructured":"Chitu V, Gokhan S, Nandi S, Mehler MF, Stanley ER. Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci. 2016;39(6):378\u201393.","journal-title":"Trends Neurosci"},{"key":"3945_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnagi.2017.00244","volume":"9","author":"DG Walker","year":"2017","unstructured":"Walker DG, Tang TM, Lue LF. Studies on colony stimulating factor receptor-1 and ligands colony stimulating factor-1 and interleukin-34 in Alzheimer\u2019s disease brains and human microglia. Front Aging Neurosci. 2017;9:244.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"3945_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41419-020-03084-7","volume":"11","author":"N Hagan","year":"2020","unstructured":"Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 2020;11(10):904.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3945_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-8993(94)91779-5","volume":"639","author":"H Akiyama","year":"1994","unstructured":"Akiyama H, Nishimura T, Kondo H, Ikeda K, Hayashi Y, McGeer PL. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Brain Res. 1994;639(1):171\u20134.","journal-title":"Brain Res"},{"issue":"5","key":"3945_CR8","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","volume":"116","author":"AG Horti","year":"2019","unstructured":"Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, et al. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc Natl Acad Sci U S A. 2019;116(5):1686\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3945_CR9","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1021\/acs.jmedchem.7b00873","volume":"61","author":"MI El-Gamal","year":"2018","unstructured":"El-Gamal MI, Al-Ameen SK, Al-Koumi DM, Hamad MG, Jalal NA, Oh CH. Recent advances of colony-stimulating factor-1 receptor (CSF-1R) kinase and its inhibitors. J Med Chem. 2018;61(13):5450\u201366.","journal-title":"J Med Chem"},{"issue":"Pt 3","key":"3945_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain. 2016;139(Pt 3):891\u2013907.","journal-title":"Brain"},{"key":"3945_CR11","doi-asserted-by":"publisher","first-page":"789834","DOI":"10.3389\/fnagi.2021.789834","volume":"13","author":"B Hu","year":"2021","unstructured":"Hu B, Duan S, Wang Z, Li X, Zhou Y, Zhang X, et al. Insights into the role of CSF1R in the central nervous system and neurological disorders. Front Aging Neurosci. 2021;13:789834.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3945_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00018-022-04225-1","volume":"79","author":"J Han","year":"2022","unstructured":"Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges. Cell Mol Life Sci. 2022;79(4):219.","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 4","key":"3945_CR13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain. 2016;139(Pt 4):1265\u201381.","journal-title":"Brain"},{"key":"3945_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R, et al. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation. 2015;12:139.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3945_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00401-024-02816-9","volume":"148","author":"M Shanaki Bavarsad","year":"2024","unstructured":"Shanaki Bavarsad M, Spina S, Oehler A, Allen IE, Suemoto CK, Leite REP, et al. Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation. Acta Neuropathol. 2024;148(1):58.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3945_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122(1):111\u20133.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3945_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","journal-title":"Acta Neuropathol"},{"key":"3945_CR18","doi-asserted-by":"publisher","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG, Beach TG, Duyckaerts C, Ferrer IA, Gelpi E, et al. Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol. 2022;144(7):603\u201314. https:\/\/doi.org\/10.1007\/s00401-022-02479-4.","DOI":"10.1007\/s00401-022-02479-4"},{"key":"3945_CR19","doi-asserted-by":"publisher","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, Hepker M, Hwang JH, Miller ZA, Huang EJ, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease. Brain. 2021;144(7):2186\u201398. https:\/\/doi.org\/10.1093\/brain\/awab099.","DOI":"10.1093\/brain\/awab099"},{"issue":"4","key":"3945_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4103\/1673-5374.322451","volume":"17","author":"L Bo","year":"2022","unstructured":"Bo L, Bo X. Colony stimulating factor 1: friend or foe of neurons? Neural Regen Res. 2022;17(4):773\u20134.","journal-title":"Neural Regen Res"},{"issue":"1","key":"3945_CR21","doi-asserted-by":"publisher","first-page":"12353","DOI":"10.1038\/s41598-019-48787-w","volume":"9","author":"S Jolly","year":"2019","unstructured":"Jolly S, Lang V, Koelzer VH, Sala Frigerio C, Magno L, Salinas PC, et al. Single-cell quantification of mRNA expression in the human brain. Sci Rep. 2019;9(1):12353.","journal-title":"Sci Rep"},{"key":"3945_CR22","unstructured":"The Definitive ISH Guide [https:\/\/www.bio-techne.com\/reagents\/rnascope-ish-technology\/rnascope\/rnascope-ish-reference-guide]"},{"issue":"6","key":"3945_CR23","doi-asserted-by":"publisher","first-page":"fcae430","DOI":"10.1093\/braincomms\/fcae430","volume":"6","author":"CA Hurler","year":"2024","unstructured":"Hurler CA, Liebscher S, Arzberger T, Jakel S. Impact of fixation duration on messenger RNA detectability in human formalin-fixed paraffin-embedded brain tissue. Brain Commun. 2024;6(6):fcae430.","journal-title":"Brain Commun"},{"issue":"6","key":"3945_CR24","doi-asserted-by":"publisher","first-page":"fcac256","DOI":"10.1093\/braincomms\/fcac256","volume":"4","author":"M Papalampropoulou-Tsiridou","year":"2022","unstructured":"Papalampropoulou-Tsiridou M, Shiers S, Wang F, Godin AG, Price TJ, De Koninck Y. Distribution of acid-sensing ion channel subunits in human sensory neurons contrasts with that in rodents. Brain Commun. 2022;4(6):fcac256.","journal-title":"Brain Commun"},{"issue":"9280","key":"3945_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461\u20137.","journal-title":"Lancet"},{"issue":"2","key":"3945_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","volume":"38","author":"M Yokokura","year":"2011","unstructured":"Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"36","key":"3945_CR27","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1523\/JNEUROSCI.2574-18.2019","volume":"39","author":"L Passamonti","year":"2019","unstructured":"Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, et al. Neuroinflammation and functional connectivity in Alzheimer\u2019s disease: interactive influences on cognitive performance. J Neurosci. 2019;39(36):7218\u201326.","journal-title":"J Neurosci"},{"issue":"6","key":"3945_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ana.20332","volume":"56","author":"A Cagnin","year":"2004","unstructured":"Cagnin A, Rossor M, Sampson EL, MacKinnon T, Banati RB. In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol. 2004;56(6):894\u20137.","journal-title":"Ann Neurol"},{"issue":"3","key":"3945_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2020-323698","volume":"92","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Rittman T, Jones PS, Cope TE, Passamonti L, Bevan-Jones WR, et al. In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2021;92(3):319\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3945_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/brain\/awaa033","volume":"143","author":"WR Bevan-Jones","year":"2020","unstructured":"Bevan-Jones WR, Cope TE, Jones PS, Kaalund SS, Passamonti L, Allinson K, et al. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain. 2020;143(3):1010\u201326.","journal-title":"Brain"},{"issue":"6","key":"3945_CR31","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/ana.25911","volume":"88","author":"M Malpetti","year":"2020","unstructured":"Malpetti M, Passamonti L, Rittman T, Jones PS, Vazquez Rodriguez P, Bevan-Jones WR, et al. Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy. Ann Neurol. 2020;88(6):1194\u2013204.","journal-title":"Ann Neurol"},{"issue":"7","key":"3945_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","volume":"92","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Passamonti L, Jones PS, Street D, Rittman T, Fryer TD, et al. Neuroinflammation predicts disease progression in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2021;92(7):769\u201375.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3945_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13550-024-01133-2","volume":"14","author":"CA Foss","year":"2024","unstructured":"Foss CA, Naik R, Das D, Cha H, Minn I, Hall A, et al. A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues. EJNMMI Res. 2024;14(1):76.","journal-title":"EJNMMI Res"},{"issue":"4-5","key":"3945_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000457127","volume":"17","author":"R Taipa","year":"2017","unstructured":"Taipa R, Brochado P, Robinson A, Reis I, Costa P, Mann DM, et al. Patterns of microglial cell activation in Alzheimer disease and frontotemporal lobar degeneration. Neurodegener Dis. 2017;17(4\u20135):145\u201354.","journal-title":"Neurodegener Dis"},{"issue":"6","key":"3945_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","volume":"21","author":"SE Arnold","year":"2000","unstructured":"Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ. Quantitative neurohistological features of frontotemporal degeneration. Neurobiol Aging. 2000;21(6):913\u20139.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"3945_CR36","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ana.25240","volume":"83","author":"G Kim","year":"2018","unstructured":"Kim G, Bolbolan K, Gefen T, Weintraub S, Bigio EH, Rogalski E, et al. Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol. 2018;83(6):1096\u2013104.","journal-title":"Ann Neurol"},{"issue":"5","key":"3945_CR37","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1212\/WNL.0000000000004891","volume":"90","author":"G Kim","year":"2018","unstructured":"Kim G, Vahedi S, Gefen T, Weintraub S, Bigio EH, Mesulam MM, et al. Asymmetric TDP pathology in primary progressive aphasia with right hemisphere language dominance. Neurology. 2018;90(5):e396\u2013403.","journal-title":"Neurology"},{"issue":"1","key":"3945_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12974-020-01907-0","volume":"17","author":"IOC Woollacott","year":"2020","unstructured":"Woollacott IOC, Toomey CE, Strand C, Courtney R, Benson BC, Rohrer JD, et al. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration. J Neuroinflammation. 2020;17(1):234.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"3945_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","volume":"17","author":"R Fernandez-Botran","year":"2011","unstructured":"Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW, et al. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord. 2011;17(9):683\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"3945_CR40","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1093\/brain\/awac257","volume":"145","author":"KB Casaletto","year":"2022","unstructured":"Casaletto KB, Nichols E, Aslanyan V, Simone SM, Rabin JS, La Joie R, et al. Sex-specific effects of microglial activation on Alzheimer\u2019s disease proteinopathy in older adults. Brain. 2022;145(10):3536\u201345.","journal-title":"Brain"},{"issue":"1","key":"3945_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"MV Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier MV, Araiz AR, Mela V, Gaban AS, O\u2019Neill E, Joshi L, et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun Biol. 2021;4(1):711.","journal-title":"Commun Biol"},{"issue":"4","key":"3945_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn AD, Grinberg LT. Is Alzheimer disease a disease? Nat Rev Neurol. 2024;20(4):245\u201351.","journal-title":"Nat Rev Neurol"},{"key":"3945_CR43","doi-asserted-by":"crossref","unstructured":"Spina S, Joie RL, Petersen C, Nolan AL, Cuevas D, Cosme C, Hepker M, Hwang J-H, Miller ZA, Huang EJ et al. Comorbid neuropathological diagnoses in early vs late-onset Alzheimer\u2019s disease. Brain 2021, In press.","DOI":"10.1101\/2020.10.14.20213017"},{"key":"3945_CR44","doi-asserted-by":"publisher","unstructured":"Mehta RI, Keith CM, Teixeira CVL, Worhunsky PD, Phelps HE, Ward M, Miller M, Navia RO, Pockl S, Rajabalee N, et al. The early-onset Alzheimer's disease MRI signature: a replication and extension analysis in early-stage AD. Cereb Cortex. 2024;34(12):bhae475. https:\/\/doi.org\/10.1093\/cercor\/bhae475.","DOI":"10.1093\/cercor\/bhae475"},{"issue":"8","key":"3945_CR45","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","volume":"34","author":"C Moller","year":"2013","unstructured":"Moller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, et al. Different patterns of gray matter atrophy in early- and late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2013;34(8):2014\u201322.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3945_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.20120412","volume":"210","author":"J Luo","year":"2013","unstructured":"Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, Ding Z, et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med. 2013;210(1):157\u201372.","journal-title":"J Exp Med"},{"issue":"2","key":"3945_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2020;140(2):99\u2013119.","journal-title":"Acta Neuropathol"},{"key":"3945_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369\u201389.","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"3945_CR49","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","volume":"38","author":"L Rajendran","year":"2018","unstructured":"Rajendran L, Paolicelli RC. Microglia-mediated synapse loss in Alzheimer\u2019s disease. J Neurosci. 2018;38(12):2911\u20139.","journal-title":"J Neurosci"},{"issue":"2","key":"3945_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82(2):380\u201397.","journal-title":"Neuron"},{"issue":"9","key":"3945_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","volume":"41","author":"KN Green","year":"2020","unstructured":"Green KN, Crapser JD, Hohsfield LA. To kill a microglia: a case for CSF1R inhibitors. Trends Immunol. 2020;41(9):771\u201384.","journal-title":"Trends Immunol"},{"key":"3945_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbi.2023.07.011","volume":"113","author":"W Wang","year":"2023","unstructured":"Wang W, Li Y, Ma F, Sheng X, Chen K, Zhuo R, et al. Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer\u2019s disease model by restoring BDNF signaling. Brain Behav Immun. 2023;113:275\u201388.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3945_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Bruck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133(1):13\u201324.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3945_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001;50(3):389\u2013400.","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"3945_CR55","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128(Pt 11):2705\u201312.","journal-title":"Brain"},{"issue":"Pt 4","key":"3945_CR56","first-page":"1089","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(Pt 4):1089\u2013104.","journal-title":"Brain"},{"issue":"Pt 9","key":"3945_CR57","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011;134(Pt 9):2755\u201371.","journal-title":"Brain"},{"issue":"Pt 5","key":"3945_CR58","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132(Pt 5):1175\u201389.","journal-title":"Brain"},{"issue":"5","key":"3945_CR59","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015;78(5):710\u201321.","journal-title":"Ann Neurol"},{"key":"3945_CR60","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2018","unstructured":"Lassmann H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol. 2018;9:3116.","journal-title":"Front Immunol"},{"issue":"12","key":"3945_CR61","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","volume":"76","author":"M Absinta","year":"2019","unstructured":"Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. 2019;76(12):1474\u201383.","journal-title":"JAMA Neurol"},{"key":"3945_CR62","doi-asserted-by":"publisher","unstructured":"Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS. A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature. 2021;597(7878):709\u201314. https:\/\/doi.org\/10.1038\/s41586-021-03892-7.","DOI":"10.1038\/s41586-021-03892-7"},{"issue":"7","key":"3945_CR63","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of \u201chomeostatic\u201d microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140(7):1900\u201313.","journal-title":"Brain"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03945-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:02:15Z","timestamp":1790258535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03945-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3945"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03945-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable because this study is considered non-human as it uses de-identified postmortem brain samples.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LTG, MS, GDR, AR and WJ received research grants from the Alliance for Therapies in Neuroscience, a partnership between the Weill Neurohub and Roche Genentech Inc.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"320"}}